产品中心

Product center

CP21R7 98%

CP21R7

源叶(MedMol)
S81266
125314-13-8
C19H15N3O2
317.3413
品牌 货号 产品规格 价格(RMB) 库存(上海) 北京 武汉 南京 购买数量
源叶(MedMol) S81266-1mg 98% ¥120.00元 9 - - -
源叶(MedMol) S81266-5mg 98% ¥194.00元 >10 - - -
源叶(MedMol) S81266-10mg 98% ¥330.00元 >10 - - -
源叶(MedMol) S81266-25mg 98% ¥660.00元 >10 - - -
源叶(MedMol) S81266-50mg 98% ¥1120.00元 预计交期:2-3天 - - -
源叶(MedMol) S81266-100mg 98% ¥1910.00元 预计交期:2-3天 - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品

产品介绍

CP21R7 is potent GSK-3β inhibitor, with an IC50 of 1.8 nM; CP21R7 also shows inhibitory activitiy against PKCα, with an IC50 of 1900 nM.
产品描述: CP21R7 is potent GSK-3β inhibitor, with an IC50 of 1.8 nM; CP21R7 also shows inhibitory activitiy against PKCα, with an IC50 of 1900 nM.
靶点: GSK-3β:1.8 nM (IC50);PKCα:1900 nM (IC50);GSK-3; PKC
体外研究:
CP21R7 (Compound 9) is a selective inhibitor of GSK-3β, with an IC50 of 1.8 nM; the IC50 of CP21R7 against PKCα is 1900 nM. CP21R7 (CP21, 3 μM) potently activates canonical Wnt signaling with highest activity. CP21 significantly increases total levels of intracellular β-catenin. CP21 combined with BMP4 induces commitment of hPSCs towards mesoderm
参考文献:
1. Gong L, et al. Discovery of potent and bioavailable GSK-3beta inhibitors. Bioorg Med Chem Lett. 2010 Mar 1;20(5):1693-6. 2. Patsch C, et al. Generation of vascular endothelial and smooth muscle cells from human pluripotent stem cells. Nat Cell Biol. 2015 Aug;17(8):994-1003.
溶解性: soluble  in  DMSO
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 3.151 ml 15.756 ml 31.512 ml
5 mM 0.63 ml 3.151 ml 6.302 ml
10 mM 0.315 ml 1.576 ml 3.151 ml
50 mM 0.063 ml 0.315 ml 0.63 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:C10000001 货号:A800001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×

相关产品